Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04609917 |
|
Recruitment Status :
Completed
First Posted : October 30, 2020
Last Update Posted : October 30, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Endoscopic Retrograde Cholangiopancreatography (ERCP) is one of the most technically challenging procedures in gastrointestinal endoscopy. Selective deep cannulation is a critical step for the performance of ERCP. The incidence of difficult cannulation has been reported in many studies, ranging from 10% to 40% in patients with native papilla. Difficult cannulation is an independent risk factor for post-ERCP pancreatitis (PEP).
The definition of difficult cannulation has been proposed by European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Initial cannulation is considered difficult with the presence of one or more of the following: more than 5 min for attempting to cannulate; more than 5 contacts with the papilla; more than 1 unintended pancreatic duct cannulation or opacification. The clear definition of difficult cannulation is important for making decisions during or after ERCP, including determining the appropriate time to transfer to advanced cannulation techniques (e.g. early precut) and whether prophylactic methods should be administrated to reduce the risk of PEP. Although 5-5-1 criteria have been widely used during ERCP practice or in relevant studies, it remains unclear whether the current criteria are suitable for the cannulation procedure with trainee involvement. Because of inexperienced manipulation of the scope and accessories, the involvement of trainees generally increases the overall cannulation time and attempts, which are the two important parameters in the criteria of difficult cannulation. Thus, the investigators hypothesized that the definition of difficult cannulation in trainee-involved cannulation might be different from the traditional 5-5-1 criteria.
| Condition or disease | Intervention/treatment |
|---|---|
| Biliary Cannulation Endoscopic Retrograde Cholangiopancreatography | Procedure: trainee invlovement |
| Study Type : | Observational |
| Actual Enrollment : | 4415 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Retrospective |
| Official Title: | Proposal of Difficult Cannulation Criteria in Trainee Involved ERCP Cannulation Procedure |
| Actual Study Start Date : | March 1, 2020 |
| Actual Primary Completion Date : | October 1, 2020 |
| Actual Study Completion Date : | October 20, 2020 |
| Group/Cohort | Intervention/treatment |
|---|---|
|
trainee group
Patients with native papilla who underwent selective biliary cannulation with trainee involvement
|
Procedure: trainee invlovement
Patients underwent selective biliary cannulation with trainee involvement |
|
non-trainee group
Patients with native papilla who underwent selective biliary cannulation without trainee involvement
|
- rates of difficult cannulation [ Time Frame: 2 hours ]The proportion of the participants with cannulation-related parameters (cannulation time, cannulation attempts, or inadvertent PD cannulation) above the 75% percentile
- incidences of PEP [ Time Frame: 48 hours ]
- overall adverse events [ Time Frame: 48 hours ]
- the proportion of advanced cannulation methods [ Time Frame: 4 hours ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- patients with native papilla
Exclusion Criteria:
- indications of major or minor pancreatic duct (PD) cannulation; no attempts of cannulation due to inaccessible papilla; cannulation via the papillary fistula; patients with duodenal stenosis or anatomical deformity secondary to prior surgery.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04609917
| China, Shaanxi | |
| Endoscopic center, Xijing Hospital of Digestive Diseases | |
| Xi'an, Shaanxi, China, 710032 | |
| Responsible Party: | Yanglin Pan, Associate Professor, Air Force Military Medical University, China |
| ClinicalTrials.gov Identifier: | NCT04609917 |
| Other Study ID Numbers: |
KY20201021-2 |
| First Posted: | October 30, 2020 Key Record Dates |
| Last Update Posted: | October 30, 2020 |
| Last Verified: | October 2020 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
ERCP Difficult cannulation Trainee PEP |

